Two independent teams described potential roles for gut microbes, and the compounds they produce, in schizophrenia, depression, and mental quality of life.
The parties will test and implement BioLegend's TotalSeq antibodies as part of a workflow combing single-cell proteomics with single-cell transcriptomics.
Researchers from Belgium analyzed the transcriptomes of almost 100,000 single cells from lung cancer patients, most of them stromal cells.
Gut microbiome researchers have identified features associated with everything from Crohn's disease to salt intake, immune activity, and hypertension.
Researchers sequenced and analyzed the genome of Apostasia shenzhenica, which is part of a small sister lineage to other plants in the Orchidaceae family, uncovering new evolutionary clues.
The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.
The blood-based test will use a 23-gene expression signature identified by researchers at VIB-KU Leuven and their collaborators.
The institutes will exchange investigators, form research collaborations in various areas of plant biotechnology, and start new companies together.
With the help of TCGA sequence data, researchers uncovered expression of a long, non-coding RNA called SAMMSON that appears to be specific to melanoma.
The new R9 pore, which the company has licensed from VIB in Belgium and plans to release for the MinIon and the PromethIon, is based on the E. coli CsgG nanopore.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.